Average-risk women overestimate ovarian cancer risk

Average-risk women overestimate ovarian cancer risk

(HealthDay)—Average-risk, postmenopausal women overestimate their risk of ovarian cancer, but report low cancer worry, according to a study published in the March issue of the American Journal of Obstetrics and Gynecology.

Laura L. Holman, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues surveyed 925 average-risk, enrolled in the normal-risk ovarian screening study. The authors sought to assess the women's baseline knowledge of risk and perceptions toward ovarian cancer screening (OCS). Baseline surveys included risk perception, the Cancer Worry Scale, State-Trait Anxiety Inventory (STAI), and the Short Form-36 Health Survey, as well as surveys relating to and OCS acceptability.

The researchers found that participants estimated the mean lifetime ovarian cancer risk as 29.9 percent, considerably higher than the actual risk of 1.4 percent in the United States. More than one-third (35.4 percent) of participants estimated their lifetime risk to be ≥50 percent, and only 2.8 percent estimated their risk correctly. Cancer worry was low, with a median score of 7 out of 24, and anxiety was similar to published norms for this age group (STAI-State and STAI-Trait scores of 30 and 29, respectively, out of 80). Almost all respondents (97.2 percent) agreed or strongly agreed that the benefits of OCS outweighed the difficulties. Reluctance to undergo OCS was rarely due to time constraints, pain, or embarrassment (1.1, 2.0, and 1.9 percent, respectively).

"The discrepancy between knowledge of and attitudes toward ovarian cancer risk highlights the need for educational efforts in this area," the authors write.

One author disclosed financial ties to the pharmaceutical industry. A second author is a faculty member at Massachusetts General Hospital, which has licensed the Risk of Ovarian Cancer Algorithm.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Excess weight a risk factor for ovarian cancer

Mar 11, 2014

(HealthDay)—A new report reveals that excess weight raises the risk of yet another kind of cancer, with the latest results linking levels of body fat to ovarian tumors.

Biomarkers predict time to ovarian cancer recurrence

Aug 15, 2013

Ovarian cancer often remains undetected until it is at an advanced stage. Despite positive responses to initial treatment, many patients are at risk of tumor recurrence. A multitude of genetic markers have been implicated ...

Recommended for you

Is egg freezing an empowering option for women?

Nov 17, 2014

Katie Hammond, a PhD candidate in the Department of Sociology researching the experience of egg donation in Canada, discusses the recent decision by tech giants Facebook and Apple to offer egg freezing to ...

Peripheral nerve blocks OK for migraines in pregnancy

Nov 14, 2014

(HealthDay)—For migraines that do not respond to medications, peripheral nerve blocks may be a treatment option in pregnant women, according to research published online Nov. 5 in Obstetrics & Gynecology.

Hearing the heart of the mother and her baby

Nov 14, 2014

A group of students from the Autonomous Metropolitan University of Mexico (UAM-I) developed a technological portable prototype able to diagnose health conditions in the mother and in the baby by monitoring ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.